222 related articles for article (PubMed ID: 31561440)
21. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
Haid S; Windisch MP; Bartenschlager R; Pietschmann T
J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
[TBL] [Abstract][Full Text] [Related]
22. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability.
Liao Z; Yang Z; Piontek A; Eichner M; Krause G; Li L; Piontek J; Zhang J
Neuroscience; 2016 Jul; 327():53-63. PubMed ID: 27095710
[TBL] [Abstract][Full Text] [Related]
23. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
[TBL] [Abstract][Full Text] [Related]
24. Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
Mitchell LA; Koval M
Toxins (Basel); 2010 Jul; 2(7):1595-611. PubMed ID: 22069652
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
26. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.
Kimura J; Abe H; Kamitani S; Toshima H; Fukui A; Miyake M; Kamata Y; Sugita-Konishi Y; Yamamoto S; Horiguchi Y
J Biol Chem; 2010 Jan; 285(1):401-8. PubMed ID: 19903817
[TBL] [Abstract][Full Text] [Related]
27. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
28. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
Shrestha A; McClane BA
mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.
Fofana I; Zona L; Thumann C; Heydmann L; Durand SC; Lupberger J; Blum HE; Pessaux P; Gondeau C; Reynolds GM; McKeating JA; Grunert F; Thompson J; Zeisel MB; Baumert TF
J Virol; 2013 Sep; 87(18):10405-10. PubMed ID: 23864633
[TBL] [Abstract][Full Text] [Related]
30. cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids.
Waldow A; Beier LS; Arndt J; Schallenberg S; Vollbrecht C; Bischoff P; Farrera-Sal M; Loch FN; Bojarski C; Schumann M; Winkler L; Kamphues C; Ehlen L; Piontek J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514167
[TBL] [Abstract][Full Text] [Related]
31. Claudin-Targeted Suicide Gene Therapy for Claudin-Overexpressing Tumor Cells by Using Modified Clostridium perfringens Enterotoxin (CPE).
Beier LS; Piontek J; Piontek A; Protze J; Kobelt D; Walther W
Methods Mol Biol; 2022; 2521():173-188. PubMed ID: 35732998
[TBL] [Abstract][Full Text] [Related]
32. The interaction of Clostridium perfringens enterotoxin with receptor claudins.
Shrestha A; Uzal FA; McClane BA
Anaerobe; 2016 Oct; 41():18-26. PubMed ID: 27090847
[TBL] [Abstract][Full Text] [Related]
33. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
[TBL] [Abstract][Full Text] [Related]
34. Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
Torres JB; Mosley M; Koustoulidou S; Hopkins S; Knapp S; Chaikuad A; Kondoh M; Tachibana K; Kersemans V; Cornelissen B
J Nucl Med; 2020 Dec; 61(12):1756-1763. PubMed ID: 32414951
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin.
Shinoda T; Shinya N; Ito K; Ohsawa N; Terada T; Hirata K; Kawano Y; Yamamoto M; Kimura-Someya T; Yokoyama S; Shirouzu M
Sci Rep; 2016 Sep; 6():33632. PubMed ID: 27647526
[TBL] [Abstract][Full Text] [Related]
36. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins.
Hopcraft SE; Evans MJ
Hepatology; 2015 Oct; 62(4):1059-69. PubMed ID: 25820616
[TBL] [Abstract][Full Text] [Related]
37. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
Padmanabhan P; Dixit NM
PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
[TBL] [Abstract][Full Text] [Related]
38. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.
Clément CMH; Deffieu MS; Dorobantu CM; Baumert TF; Ayala-Nunez NV; Mély Y; Ronde P; Gaudin R
Biol Cell; 2020 May; 112(5):140-151. PubMed ID: 32034780
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
